Market Update (NYSE:DHR): Danaher To Present At Goldman Sachs Global Healthcare Conference

[PR Newswire] – WASHINGTON, June 2, 2016 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr. will be presenting at the Goldman Sachs Global Healthcare … Read more on this. Danaher Corp. (DHR) , with a current value of $67.93B, opened at $98.08. Looking at the equity, the company’s one day range is $97.82 to $98.72 with a trailing 52-week range being $81.25 to $100.50. Priced at 20.01x this year’s forecasted earnings, DHR shares are relatively expensive compared to the industry’s 15.59x forward p/e ratio. The company pays shareholders $0.64 per share annually in dividends, yielding 0.65%. Consensus earnings for the current quarter by the 17 sell-side analysts covering the stock is an estimate of $1.22 per share, which would be $0.14 better than the year-ago quarter and a $0.02 sequential decrease. In looking at the bigger picture, the full-year EPS estimate of $4.93 would be a $0.63 better when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $5.76 Billion. If realized, that would be a 12.28% increase over the year-ago quarter. More recently, Bernstein downgraded DHR from Outperform to Mkt Perform (Apr 4, 2016). Previously, Sterne Agee CRT Initiated DHR at to Neutral. When considering if the stock is under or overvalued, the average price target is $103.92, which is 5.95% above where the stock opened this morning. See more in (NYSE:DHR) Similar Articles: Market Update (NYSE:DHR): Danaher To Present At Bernstein Strategic Decisions Conference Market Update: Danaher Corporation (NYSE:DHR) – Danaher To Present At Electrical Products Group Conference Company Update: Danaher Corporation (NYSE:DHR) – Danaher Schedules First Quarter 2016 Earnings Conference Call